ALDER BIOPHARMACEUTICALS
Alder's mission is to help alleviate human suffering by generating better and safer antibody therapeutics through novel technologies. Alder plays two roles: As a biopharmaceutical company, Alder uses its proprietary technologies to uniquely identify, develop, produce and market its own antibody therapeutics. The work being done at Alder today will help those who suffer from cancer, autoimmune diseases, and inflammatory diseases. As a licensing partner, Alder is revolutionizing the way th... e pharmaceutical industry discovers, develops and produces antibody therapeutics. Through various licensing agreements, Alder has used its proprietary technology to help major biopharmaceutical partners advance novel therapeutics to the clinic in less time and at lower cost. Alder's licensing strategy also includes identifying strategic partners to assist in the development and marketing of its preclinical and clinical pipeline programs.
ALDER BIOPHARMACEUTICALS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2004-01-01
Address:
Bothell, Washington, United States
Country:
United States
Website Url:
http://www.alderbio.com
Total Employee:
101+
Status:
Active
Contact:
425-205-2900
Email Addresses:
[email protected]
Total Funding:
525 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail IPv6 Google Maps Microsoft Azure DNS Google Maps API Pound Sterling Microsoft
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Xeris Pharmaceuticals
Xeris Pharmaceuticals is a pharmaceutical company that develops therapies for patients in endocrinology, neurology, and gastroenterology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Redmile Group
Redmile Group investment in Post-IPO Equity - Alder Biopharmaceuticals
Sevin Rosen Funds
Sevin Rosen Funds investment in Series D - Alder Biopharmaceuticals
TPG Biotech
TPG Biotech investment in Series D - Alder Biopharmaceuticals
Novo Ventures
Novo Ventures investment in Series D - Alder Biopharmaceuticals
Delphi Ventures
Delphi Ventures investment in Series D - Alder Biopharmaceuticals
Ventures West
Ventures West investment in Series D - Alder Biopharmaceuticals
H.I.G. Capital
H.I.G. Capital investment in Series D - Alder Biopharmaceuticals
Washington Research Foundation
Washington Research Foundation investment in Series D - Alder Biopharmaceuticals
TPG Biotech
TPG Biotech investment in Series C - Alder Biopharmaceuticals
Delphi Ventures
Delphi Ventures investment in Series C - Alder Biopharmaceuticals
Official Site Inspections
http://www.alderbio.com
- Host name: cloudproxy10060.sucuri.net
- IP address: 192.124.249.60
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
